HIV protease (E. C. # EC 3.4.23.16), a virally-encoded aspartic protease belonging to the Retropepsin A2 proteinase family. It is produced following HIV infection of host cells, and processes the gag and gag-pol proteins required during the early replication phase of the virus. Several inhibitors of HIV protease have been developed as successful therapeutic agents. HIV protease is a dimer with a monomer MW of 10,779. Sigma's HIV protease is supplied in the inactive form as a solution in 20 mM HCl. Reactivation occurs when the enzyme is reconstituted in buffers in the pH range of 4 to 7.
| HIV Protease |
|
| Product Name |
Product # |
| HIV Protease, suitable for cleaving HIV substrate III |
P7338 |
| HIV Protease Inhibitor |
back to top |
| Product Name |
Product # |
| a-MAPI, Phe-urea-Arg-Val-Phe-CHO |
M9812 |
| HIV Protease Substrates |
back to top |
| Product Name |
Product # |
| Acetyl-Ser-Gln-Asn-Tyr-Pro-Val-Val amide |
A0806 |
| Anthranilyl-His-Lys-Ala-Arg-Val-Leu-p-nitro-Phe-Glu-Ala-Nle-Ser amide |
A0811 |
| His-Lys-Ala-Arg-Val-Leu-p-nitro-Phe-Glu-Ala-Nle-Ser amide |
H5397 |
| HIV Protease Substrate 1 |
H6660 |
| HIV Protease Substrate III-B, Native Sequence |
H5285 |
| HIV Protease Substrate V |
H5410 |
| HIV Protease Substrate VI |
H5535 |
| HIV Protease Substrate VII |
H5660 |
| HIV Protease Substrate VIII |
H5785 |
| Anthranilyl-HIV Protease Substrate |
H5910 |
| Anthranilyl-HIV Protease Substrate V |
H6035 |
| Anthranilyl-HIV Protease Substrate VI |
H6160 |
| Lys-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle amide |
L6525 |
| HIV Proteins |
back to top |
| Product Name |
Product # |
| HIV-1 env antigen human, recombinant |
H9909 |
| HIV Envelope protein (gp41) Fragment 579-601 |
H4521 |
| HIV Envelope protein (gp120) Fragment 254-274 |
H7769 |
| HIV-1 gag |
H0160 |
| HIV Envelope protein (gp120) Fragment 308-331 |
H7894 |
| HIV Envelope protein (gp120) Fragment 421-438 |
H6153 |
| HIV-1 nef human |
H0285 |
